Arkolith/Insider Trading/NKGN/Form 4

Graf Acquisition Partners IV LLC

10% OwnerNKGen Biotech, Inc. (NKGN) · full profile →Form 4 · filed Dec 23, 2024
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
8
3 non-derivative · 5 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Dec 18, 2024Other(J)110K—$02.1M
Dec 16, 2024Other(J)83K—$02.3M
Dec 2, 2024Other(J)97K—$02.3M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Dec 18, 2024Disposed to issuer(D)267K——190K
Dec 18, 2024Disposed to issuer(D)892K——1.9M
Dec 16, 2024Disposed to issuer(D)1.2M——2.8M
Dec 16, 2024Disposed to issuer(D)67K——456K
Dec 2, 2024Disposed to issuer(D)713K——4.0M

Transaction Codes

J
Other acquisition / disposition
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-24-111880) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML